Panel Discussion | Digital Health and Clinical Trials, DOGE and its Influence of Cardiovascular Device Approvals

Tuesday, March 11, 2025

11:42 AM - 12:15 PM ET

Panel Moderator(s)

Joaquin E. Cigarroa, MD

Director, Knight Cardiovascular Institute
OHSU Knight Cardiovascular Institute
Portland, Oregon, United States

No relationships to disclose
Ron Waksman, MD, MSCAI

Director, Cardiovascular Research and Advanced Education
MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
Washington, District of Columbia, United States

Disclosure(s): Abbott Vascular: Grant/Research Support (Ongoing); Biotronik: Consultant (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Chiesi USA: Grant/Research Support (Ongoing)

Panel Discussant(s)

Dorothy B. Abel, BSBME

Partner
Abel and Wolf Consulting
Santa Rosa, California, United States

Disclosure information not submitted.
Mona Advani, M.Sc., MBA

Principal Regulatory Consultant
CardioMed Device Consultants
HERNDON, Virginia, United States

No relationships to disclose
Robert M. Califf, MD

Instructor in Medicine
Duke University School of Medicine
Durham, North Carolina, United States

Disclosure(s): No financial relationships to disclose
C. Michael Gibson, MD

Professor of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States

No relationships to disclose
Michael C. John, MPH

United States

Disclosure(s): Xenter: Employee (Ongoing)
Aaron V. Kaplan, MD, FSCAI, FACC, FNAI

Professor of Medicine
Dartmouth Health Geisel School of Medicine at Dartmouth
Lebanon, New Hampshire, United States

Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Grant/Research Support (Ongoing); Conformal Medical, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Margaret Kayo, PhD, MBA

Regulatory Affairs
HighLife / Margaret Inc
St Augustine, Florida, United States

No relationships to disclose
David F. Kong, MD, AM, DMT

Associate Professor of Medicine
Duke University
Durham, North Carolina, United States

Disclosure(s): International Business Machines: Grant/Research Support (Ongoing)
Ernest Spitzer, MD

Chief Executive Officer
Cardialysis B.V.
Rotterdam, Zuid-Holland, Netherlands

No relationships to disclose

Disclosure(s):

Joaquin E. Cigarroa, MD: No financial relationships to disclose

Mona Advani, M.Sc., MBA: No financial relationships to disclose

Robert M. Califf, MD: No financial relationships to disclose

C. Michael Gibson, MD: Amgen: Consulting Fees (e.g., advisory boards) (Ongoing); Angel Medical Systems, Inc.: Consultant (Ongoing); Bayer HealthCare: Consultant (Ongoing)

David F. Kong, MD, AM, DMT: International Business Machines: Grant/Research Support (Ongoing)

Ernest Spitzer, MD: Abbott Labs: Grant/Research Support (Terminated, December 31, 2023); Biosensors International: Grant/Research Support (Ongoing); Boston Scientific: Grant/Research Support (Ongoing); Cardialysis: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edwards Lifesciences LLC: Grant/Research Support (Ongoing); Medtronic: Grant/Research Support (Ongoing); MicroPort Medical: Grant/Research Support (Terminated, June 30, 2024); Philips Healthcare: Grant/Research Support (Ongoing); Pie Medical: Grant/Research Support (Ongoing); shenqi Medical Technology: Grant/Research Support (Ongoing); Siemens: Grant/Research Support (Ongoing)

Robert W. Yeh, MD, MSc: Abbott Vascular, Medtronic, Boston Scientific: Consultant (Ongoing), Grant/Research Support (Ongoing); CathWorks: Consultant (Ongoing); Edward Lifesciences: Consultant (Ongoing); Elixir Medical Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Magenta Medical: Consultant (Ongoing); Shockwave Medical: Consultant (Ongoing)